Abstract
Systemic lupus erythematosus (SLE), a systemic, connective tissue disease that can affect multiple organ systems, affects women, especially Asian and African women more commonly (Silpa-archa et al. 2016). Up to one-third of SLE patients experience some kind of ocular manifestation (Palejwala et al. 2012), keratoconjunctivitis sicca being the most common form, and retinal and choroidal involvement being most associated with visual impairment (Sivaraj et al. 2007; Palejwala et al. 2012). Although, the prevalence of SLE as a cause of uveitis was estimated to be 0.47% in a recent review of the literature (Gallagher et al. 2015), ocular involvement in SLE is important as it may correlate with systemic disease activity and precede other systemic symptoms.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahn HM, Choi KS. Choroidoretinopathy and secondary angle closure attack in systemic lupus erythematosus: a case report. J Korean Ophthalmol Soc. 2016;57(11):1801–5. https://doi.org/10.3341/jkos.2016.57.11.1801.
Aronson AJ, Ordonez NG, Diddie KR, Ernest JT. Immune-complex deposition in the eye in systemic lupus erythematosus. Arch Intern Med. 1979;139(11):1312–3.
Au A, O’Day J. Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment. Clin Exp Ophthalmol. 2004;32(1):87–100.
Davies JB, Rao PK. Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol. 2008;19(6):512–8.
Dooley MA, Houssiau F, Aranow C, D’Cruz DP, Askanase A, Roth DA, Zhong ZJ, Cooper S, Freimuth WW, Ginzler EM, BLISS-52 and -76 Study Groups. Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE. Lupus. 2013;22(1):63–72. https://doi.org/10.1177/0961203312465781.
Gallagher K, Viswanathan A, Okhravi N. Association of systemic lupus erythematosus with uveitis. JAMA Ophthalmol. 2015;133(10):1190–3. https://doi.org/10.1001/jamaophthalmol.2015.2249.
Halmay O, Ludwig K. Bilateral band-shaped deep keratitis and iridocyclitis in systemic lupus erythematosus. Br J Ophthalmol. 1964;48(10):558–62.
Heron E, Gutzwiller-Fontaine M, Bourcier T. Scleritis and episcleritis: diagnosis and treatment. Rev Med Interne. 2014;35(9):577–85. https://doi.org/10.1016/j.revmed.2014.02.004.
Jabs DA, Fine SL, Hochberg MC, Newman SA, Heiner GG, Stevens MB. Severe retinal vaso-occlusive disease in systemic lupus erythematous. Arch Ophthalmol. 1986;104(4):558–63.
Kim SB, Cho WH, Chang MH. A case of severe vaso-occlusive retinopathy as the first manifestation associated with systemic lupus erythematosus. J Korean Ophthalmol Soc. 2013;54(3):518–23. https://doi.org/10.3341/jkos.2013.54.3.518.
Kurup S, Lew J, Byrnes G, Yeh S, Nussenblatt R, Levy-Clarke G. Therapeutic efficacy of intravitreal bevacizumab on posterior uveitis complicated by neovascularization. Acta Ophthalmol. 2009;87(3):349–52. https://doi.org/10.1111/j.1755-3768.2008.01208.x.
Lee WJ, Cho HY, Lee YJ, Lee BR, Shin JP. Intravitreal bevacizumab for severe vaso-occlusive retinopathy in systemic lupus erythematosus. Rheumatol Int. 2013;33(1):247–51. https://doi.org/10.1007/s00296-011-2139-9.
Levine RA, Ward PA. Experimental acute immunologic ocular vasculitis. Am J Ophthalmol. 1970;69(6):1023–31.
Navarra SV, Guzman RM, Gallacher AE, Hall S, Levy RA, Jimenez RE, Li EK, Thomas M, Kim HY, Leon MG, Tanasescu C, Nasonov E, Lan JL, Pineda L, Zhong ZJ, Freimuth W, Petri MA, BLISS-52 Study Group. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet. 2011;377(9767):721–31. https://doi.org/10.1016/S0140-6736(10)61354-2.
Nguyen QD, Uy HS, Akpek EK, Harper SL, Zacks DN, Foster CS. Choroidopathy of systemic lupus erythematosus. Lupus. 2000;9(4):288–98. https://doi.org/10.1191/096120300680199024.
Palejwala NV, Walia HS, Yeh S. Ocular manifestations of systemic lupus erythematosus: a review of the literature. Autoimmune Dis. 2012;2012:290898. https://doi.org/10.1155/2012/290898.
Read RW, Chong LP, Rao NA. Occlusive retinal vasculitis associated with systemic lupus erythematosus. Arch Ophthalmol. 2000;118(4):588–9.
Silpa-archa S, Lee JJ, Foster CS. Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol. 2016;100(1):135–41. https://doi.org/10.1136/bjophthalmol-2015-306629.
Sivaraj RR, Durrani OM, Denniston AK, Murray PI, Gordon C. Ocular manifestations of systemic lupus erythematosus. Rheumatology (Oxford). 2007;46(12):1757–62. https://doi.org/10.1093/rheumatology/kem173.
Stafford-Brady FJ, Urowitz MB, Gladman DD, Easterbrook M. Lupus retinopathy. Patterns, associations, and prognosis. Arthritis Rheum. 1988;31(9):1105–10.
Stavrou P, Murray PI, Batta K, Gordon C. Acute ocular ischaemia and orbital inflammation associated with systemic lupus erythematosus. Br J Ophthalmol. 2002;86(4):474–5.
Talat L, Lightman S, Tomkins-Netzer O. Ischemic retinal vasculitis and its management. J Ophthalmol. 2014;2014:197675. https://doi.org/10.1155/2014/197675.
Touma Z, Urowitz MB, Gladman DD. Systemic lupus erythematosus: an update on current pharmacotherapy and future directions. Expert Opin Biol Ther. 2013;13(5):723–37. https://doi.org/10.1517/14712598.2013.764411.
Yen YC, Weng SF, Chen HA, Lin YS. Risk of retinal vein occlusion in patients with systemic lupus erythematosus: a population-based cohort study. Br J Ophthalmol. 2013;97(9):1192–6. https://doi.org/10.1136/bjophthalmol-2013-303265.
Zink JM, Singh-Parikshak R, Johnson CS, Zacks DN. Hypopyon uveitis associated with systemic lupus erythematosus and antiphospholipid antibody syndrome. Graefes Arch Clin Exp Ophthalmol. 2005;243(4):386–8. https://doi.org/10.1007/s00417-004-1022-8.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Shin, J.Y. (2020). Systemic Lupus Erythematosus. In: Yu, H. (eds) Inflammatory and Infectious Ocular Disorders. Retina Atlas. Springer, Singapore. https://doi.org/10.1007/978-981-13-8546-9_13
Download citation
DOI: https://doi.org/10.1007/978-981-13-8546-9_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-8545-2
Online ISBN: 978-981-13-8546-9
eBook Packages: MedicineMedicine (R0)